Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 381: All of the following are ergot alkaloids except?

A. Ergometrine
B. Ergotoxine
C. Methysergide
D. Ketanserine (Correct Answer)

Explanation: **Explanation:** The correct answer is **Ketanserin**. **1. Why Ketanserin is the correct answer:** Ketanserin is **not** an ergot alkaloid. It is a selective **5-HT₂ receptor antagonist** that also possesses α₁-adrenoceptor blocking properties. Clinically, it is primarily used as an antihypertensive agent and to control vasospasm. Unlike ergot derivatives, it does not share the tetracyclic ergoline ring structure. **2. Why the other options are incorrect:** * **Ergometrine (Ergonovine):** A natural ergot alkaloid obtained from *Claviceps purpurea*. It is an amino alkaloid primarily used in obstetrics (PPH) due to its strong oxytocic action. * **Ergotoxine:** A natural ergot alkaloid consisting of a mixture of three alkaloids (ergocristine, ergocryptine, and ergocornine). It is a potent α-blocker and vasoconstrictor. * **Methysergide:** A semi-synthetic derivative of lysergic acid (an ergot). It is a potent 5-HT₂ antagonist previously used for the prophylaxis of migraine. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ergotism (St. Anthony’s Fire):** Poisoning caused by ergot alkaloids, characterized by severe peripheral vasoconstriction leading to gangrene and CNS effects (hallucinations). * **Drug of Choice:** Ergometrine is used for the **prophylaxis and treatment of Postpartum Hemorrhage (PPH)** but is contraindicated in patients with hypertension or toxemia of pregnancy. * **Methysergide Side Effect:** Long-term use is associated with **retroperitoneal, pleural, and endocardial fibrosis**. * **Bromocriptine:** Another semi-synthetic ergot alkaloid used as a **D2 agonist** in Parkinson’s disease and Hyperprolactinemia.

Question 382: Atropine, when used as a pre-medication, causes all of the following symptoms except?

A. Skin flush
B. Bronchoconstriction (Correct Answer)
C. Prevents bradycardia
D. Dryness of mouth

Explanation: **Explanation:** Atropine is a **competitive muscarinic antagonist** (anticholinergic) that blocks the action of acetylcholine at M1, M2, and M3 receptors. It is used as a pre-medication primarily to reduce secretions and prevent vagal-mediated bradycardia during surgery. **Why Option B is the Correct Answer:** Atropine causes **bronchodilation**, not bronchoconstriction. By blocking M3 receptors on the bronchial smooth muscle, it inhibits the parasympathetic-mediated constriction of the airways. Therefore, bronchoconstriction is the "except" symptom. **Analysis of Incorrect Options:** * **A. Skin Flush:** At high doses, atropine causes cutaneous vasodilation, particularly in the "blush area" (face/neck). This is known as **Atropine Flush**, likely a compensatory mechanism to dissipate heat since sweating is inhibited. * **C. Prevents Bradycardia:** Atropine blocks M2 receptors in the SA node, inhibiting the vagus nerve's slowing effect on the heart. This results in tachycardia, making it useful for preventing intraoperative bradycardia. * **D. Dryness of Mouth:** Atropine blocks M3 receptors on salivary glands, leading to decreased secretions (xerostomia). This is a desired pre-medication effect to prevent aspiration. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Toxicity:** "Red as a beet (flush), Dry as a bone (no sweat/saliva), Blind as a bat (mydriasis/cycloplegia), Mad as a hatter (delirium), Hot as a hare (hyperthermia)." * **Drug of Choice:** Atropine is the DOC for **symptomatic bradycardia** and **organophosphate poisoning**. * **Contraindication:** Avoid in patients with **narrow-angle glaucoma** (causes mydriasis, increasing intraocular pressure) and **Benign Prostatic Hyperplasia (BPH)** (causes urinary retention).

Question 383: Which of the following groups of drugs are neuromuscular blocking agents?

A. Choline, adrenaline, and amphetamine
B. Glycinium, neostigmine, and physostigmine
C. Pancuronium, rocuronium (Correct Answer)
D. Pirenzepine, propanolol, and propantheline

Explanation: ### Explanation **Correct Option: C (Pancuronium, Rocuronium)** Neuromuscular blocking agents (NMBAs) act at the **nicotinic acetylcholine receptors ($N_M$)** of the motor endplate to induce skeletal muscle relaxation [1], [3]. They are classified into: 1. **Non-depolarizing (Competitive):** These include the "curonium" and "curium" groups (e.g., Pancuronium, Rocuronium, Vecuronium, Atracurium) [3], [4]. They act as competitive antagonists to acetylcholine [5]. 2. **Depolarizing:** Succinylcholine (Suxamethonium) [1], [5]. **Analysis of Incorrect Options:** * **Option A:** **Choline** is a precursor for acetylcholine; **Adrenaline** is a catecholamine acting on $\alpha$ and $\beta$ receptors; **Amphetamine** is an indirect-acting sympathomimetic that releases stored norepinephrine. * **Option B:** **Neostigmine** and **Physostigmine** are anticholinesterases (AChE inhibitors) [2]. They increase acetylcholine levels and are actually used to *reverse* the blockade caused by non-depolarizing NMBAs like pancuronium [2]. * **Option D:** **Pirenzepine** and **Propantheline** are antimuscarinic drugs ($M_1$ selective and non-selective respectively). **Propranolol** is a non-selective $\beta$-blocker. **High-Yield NEET-PG Pearls:** * **Rocuronium:** Has the fastest onset of action among non-depolarizing agents, making it an alternative for rapid sequence intubation [3], [4]. * **Pancuronium:** Known for causing tachycardia due to its vagolytic effect [4]. * **Atracurium/Cisatracurium:** Undergo **Hofmann elimination** (spontaneous molecular degradation), making them the drugs of choice in patients with liver or kidney failure. * **Sugammadex:** A specific reversal agent for Rocuronium and Vecuronium that works by chelation.

Question 384: Which of the following drugs does not cross the blood-brain barrier?

A. Pralidoxime (Correct Answer)
B. Obidoxime
C. Diacetyl-monoxime
D. Physostigmine

Explanation: **Explanation:** The ability of a drug to cross the blood-brain barrier (BBB) depends primarily on its chemical structure, specifically its ionization state. **1. Why Pralidoxime (2-PAM) is the correct answer:** Pralidoxime is a **quaternary ammonium compound**. Due to the presence of a permanently charged nitrogen atom, it is highly polar and lipid-insoluble. Consequently, it **cannot cross the blood-brain barrier** and is ineffective in reversing the central nervous system (CNS) effects of organophosphate poisoning (such as respiratory depression or convulsions). It acts only peripherally to regenerate acetylcholinesterase at the neuromuscular junction. **2. Analysis of Incorrect Options:** * **Obidoxime:** Like pralidoxime, it is a quaternary oxime. However, in the context of standard NEET-PG questions, Pralidoxime is the classic prototype for a drug that does not cross the BBB. (Note: While obidoxime has poor CNS penetration, Pralidoxime is the most definitive answer regarding lack of CNS entry). * **Diacetyl-monoxime (DAM):** Unlike pralidoxime, DAM is a **tertiary amine** (non-quaternary). It is lipid-soluble and **can cross the BBB**, making it capable of regenerating cholinesterase in the CNS. * **Physostigmine:** This is a **tertiary amine** anticholinesterase. It is lipid-soluble and readily crosses the BBB. This is why it is the drug of choice for treating central anticholinergic toxicity (e.g., Atropine poisoning). **High-Yield Clinical Pearls for NEET-PG:** * **Quaternary Amine = Polar = No CNS entry** (e.g., Pralidoxime, Neostigmine, Edrophonium). * **Tertiary Amine = Non-polar = CNS entry** (e.g., Physostigmine, Atropine, DAM). * **Oxime Rule:** Oximes must be administered before "aging" of the enzyme occurs (the permanent dealkylation of the phosphorylated enzyme). * **Atropine vs. Oximes:** Atropine treats muscarinic symptoms (miosis, bradycardia) but does *not* fix muscle paralysis; Oximes treat nicotinic symptoms (muscle weakness) by regenerating the enzyme.

Question 385: A farmer visiting an orchard becomes unconscious, presenting with excessive salivation, constricted pupils, and muscle fasciculations. What is the initial treatment?

A. Atropine (Correct Answer)
B. Neostigmine
C. Physostigmine
D. Adrenaline

Explanation: ### Explanation **Correct Answer: A. Atropine** The clinical presentation—excessive salivation (secretions), constricted pupils (miosis), and muscle fasciculations—is a classic triad of **Organophosphate (OP) poisoning**, commonly seen in farmers exposed to insecticides [1], [3]. These symptoms result from the inhibition of acetylcholinesterase, leading to an "acetylcholine storm." **Atropine** is the initial drug of choice because it is a competitive muscarinic antagonist [2]. It crosses the blood-brain barrier and reverses life-threatening parasympathetic overactivity (the "Killer Bs": Bradycardia, Bronchorrhea, and Bronchospasm). While it does not reverse muscle fasciculations (a nicotinic effect), it stabilizes the patient by drying secretions and maintaining heart rate [1]. **Why other options are incorrect:** * **Neostigmine & Physostigmine:** These are acetylcholinesterase inhibitors [3]. Administering them would worsen the condition by further increasing acetylcholine levels, potentially leading to fatal respiratory failure. * **Adrenaline:** While used in anaphylaxis or cardiac arrest, it has no role in reversing the cholinergic crisis caused by OP poisoning. **NEET-PG High-Yield Pearls:** * **Endpoint of Atropinization:** The goal is not "normal" pupils, but rather the **clearing of lung crepitations** (resolution of bronchorrhea) and a heart rate >80 bpm [2]. * **Pralidoxime (2-PAM):** This is a "cholinesterase regenerator" used to treat nicotinic symptoms (like fasciculations) [4]. It must be given early, before "enzyme aging" occurs. * **Mnemonic for Muscarinic symptoms:** **DUMBELS** (Defecation, Urination, Miosis, Bronchospasm/Bradycardia, Emesis, Lacrimation, Salivation) [1].

Question 386: Which of the following is NOT an indication for the use of anticholinergics?

A. Glaucoma (Correct Answer)
B. Parkinsonism
C. Refraction testing
D. Organophosphorus poisoning

Explanation: **Explanation:** **1. Why Glaucoma is the Correct Answer:** Anticholinergics (like Atropine) cause **mydriasis** (dilation of the pupil) by blocking the M3 receptors on the sphincter pupillae. In patients with narrow-angle glaucoma, this causes the iris tissue to bunch up and block the canal of Schlemm, preventing the drainage of aqueous humor. This leads to a dangerous rise in intraocular pressure (IOP). Therefore, anticholinergics are strictly **contraindicated** in glaucoma. **2. Why the other options are incorrect (Indications):** * **Parkinsonism:** Centrally acting anticholinergics (e.g., **Benztropine, Trihexyphenidyl**) are used to restore the balance between dopamine and acetylcholine in the basal ganglia, specifically to treat drug-induced extrapyramidal symptoms. * **Refraction testing:** Anticholinergics cause **cycloplegia** (paralysis of the ciliary muscle), which is essential for accurate refraction testing in children to prevent accommodation from interfering with the measurement. * **Organophosphorus (OP) poisoning:** Atropine is the **specific antidote** for the muscarinic effects of OP poisoning. It competes with excess acetylcholine at the receptor sites to reverse life-threatening bradycardia and bronchosecretion. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for OP poisoning:** Atropine (titrated until "Atropinization" – drying of secretions and tachycardia). * **Shortest acting mydriatic:** Tropicamide (preferred for fundoscopy). * **Longest acting mydriatic:** Atropine (can last up to 7–10 days). * **Ipratropium/Tiotropium:** M3 blockers used via inhalation for COPD and Asthma. * **Glycopyrrolate:** Used pre-operatively to reduce salivary and tracheobronchial secretions.

Question 387: The main mechanism of hyperpyrexia induced by atropine includes:

A. Vasodilation
B. Inhibition of sweating (Correct Answer)
C. Through central actions
D. Increase in basal metabolic rate

Explanation: **Explanation:** The correct answer is **B. Inhibition of sweating.** **Mechanism of Action:** Atropine is a competitive antagonist of muscarinic receptors. In the Autonomic Nervous System, sweat glands are innervated by **sympathetic cholinergic fibers** (an exception where sympathetic nerves release Acetylcholine onto M3 receptors). Atropine blocks these M3 receptors, leading to **anhidrosis** (suppression of sweat). Since evaporation of sweat is the primary physiological mechanism for heat loss in humans, its inhibition leads to a rapid rise in body temperature, known as **Atropine Fever**. **Analysis of Incorrect Options:** * **A. Vasodilation:** Atropine actually causes cutaneous vasodilation (Atropine flush) as a compensatory mechanism to dissipate heat when sweating fails, but this would theoretically lower temperature, not cause hyperpyrexia. * **C. Through central actions:** While atropine crosses the blood-brain barrier and can cause CNS excitation/delirium at high doses, the primary cause of hyperpyrexia is the peripheral failure of the thermoregulatory sweating mechanism. * **D. Increase in basal metabolic rate:** Atropine does not significantly alter the BMR; the temperature rise is due to decreased heat dissipation, not increased heat production. **Clinical Pearls for NEET-PG:** * **Atropine Poisoning Mnemonic:** "Hot as a hare (hyperpyrexia), Red as a beet (flushing), Dry as a bone (anhidrosis), Blind as a bat (mydriasis), Mad as a hatter (delirium)." * **Vulnerability:** Children are particularly susceptible to atropine-induced hyperpyrexia ("Atropine Fever"), even with small doses or ophthalmic drops. * **Antidote:** **Physostigmine** (a tertiary amine carbamate) is used for poisoning because it crosses the blood-brain barrier to reverse both central and peripheral effects.

Question 388: The most likely complication of prolonged use of nasal decongestant drops is?

A. Atrophic rhinitis (Correct Answer)
B. Naso-pharyngeal moniliasis
C. Hypertrophy of nasal mucosa
D. Blockage of eustachian tubes

Explanation: **Explanation:** **Mechanism of the Correct Answer (Atrophic Rhinitis):** Nasal decongestants (e.g., Oxymetazoline, Xylometazoline) are **α-adrenergic agonists** that cause potent vasoconstriction of the nasal mucosal blood vessels. While this provides immediate relief from congestion, prolonged use (typically >5–7 days) leads to chronic ischemia of the nasal mucosa. This persistent lack of blood supply results in the atrophy of the ciliated epithelium and mucous glands, eventually leading to **Atrophic Rhinitis**. Clinically, this is often preceded by **Rhinitis Medicamentosa**, a condition characterized by "rebound congestion" where the nasal mucosa becomes more congested as the drug effect wears off, leading to a vicious cycle of overuse. **Analysis of Incorrect Options:** * **B. Naso-pharyngeal moniliasis:** This is a fungal infection (Candidiasis) typically associated with prolonged use of **inhaled or nasal corticosteroids** or immunosuppression, not sympathomimetic decongestants. * **C. Hypertrophy of nasal mucosa:** While acute rebound congestion involves swelling, long-term vascular compromise leads to **atrophy** (wasting) rather than true hypertrophy of the mucosal layers. * **D. Blockage of eustachian tubes:** Nasal decongestants are actually used therapeutically to *relieve* eustachian tube edema; they do not cause blockage as a primary complication of prolonged use. **High-Yield Clinical Pearls for NEET-PG:** * **Rhinitis Medicamentosa:** The immediate precursor to atrophy; it is treated by withdrawing the topical decongestant and starting topical nasal steroids. * **Limit of Use:** Patients should be advised not to use topical decongestants for more than **3 to 5 days**. * **Systemic Absorption:** Excessive use can lead to systemic α-effects, including hypertension and arrhythmias, especially in the elderly.

Question 389: What is the drug of choice for hyperhidrosis?

A. Phenylephrine
B. Atropine
C. Darifenacin (Correct Answer)
D. Trospium

Explanation: **Explanation:** **Hyperhidrosis** (excessive sweating) is mediated by the sympathetic nervous system; however, the postganglionic neurotransmitter involved is **Acetylcholine (ACh)** acting on **Muscarinic (M3) receptors** on eccrine sweat glands. Therefore, anticholinergic drugs are used for management. **Why Darifenacin is the correct answer:** Darifenacin is a **selective M3 receptor antagonist**. Since M3 receptors are the primary mediators of sweat gland secretion, Darifenacin effectively reduces perspiration. While traditionally used for overactive bladder, its high affinity for M3 receptors makes it a potent option for systemic control of hyperhidrosis compared to non-selective agents. **Analysis of Incorrect Options:** * **A. Phenylephrine:** This is an $\alpha_1$-adrenergic agonist. It causes vasoconstriction and mydriasis but has no inhibitory effect on sweat glands (which are cholinergic). * **B. Atropine:** While Atropine is a potent antimuscarinic that reduces sweating, it is **non-selective** (M1-M5). Its use is limited by significant side effects like tachycardia, blurred vision, and dry mouth, making it less ideal than M3-selective agents. * **D. Trospium:** This is a quaternary ammonium antimuscarinic used for overactive bladder. While it can reduce sweating, it does not cross the blood-brain barrier. However, in the context of standard MCQ patterns for M3-mediated sweat inhibition, Darifenacin is the more specific choice. **High-Yield Clinical Pearls for NEET-PG:** * **First-line Topical:** Aluminum chloride hexahydrate (20%). * **First-line Oral:** Glycopyrrolate or Oxybutynin (often preferred over Darifenacin in clinical practice due to cost/availability, but Darifenacin is pharmacologically more M3-selective). * **Procedural Choice:** Botulinum Toxin A (inhibits ACh release at the neuromuscular junction and sympathetic cholinergic fibers). * **Surgical Choice:** Endoscopic Thoracic Sympathectomy (for severe palmar hyperhidrosis).

Question 390: Which one of the following drugs is not a reversible anticholinesterase drug?

A. Edrophonium
B. Demecarium
C. Carbaryl (Correct Answer)
D. Twine

Explanation: **Explanation:** Anticholinesterases are drugs that inhibit the enzyme acetylcholinesterase (AChE), preventing the breakdown of acetylcholine. They are broadly classified into **Reversible** and **Irreversible** inhibitors based on the nature of their binding to the enzyme. **Why Carbaryl is the correct answer:** Carbaryl belongs to the **Carbamate** group of insecticides. While most carbamates used in clinical practice (like Neostigmine) are considered reversible, Carbaryl is specifically categorized as a **quasi-reversible or irreversible** inhibitor in the context of toxicology. However, the key reason it is the odd one out here is that it is a **pesticide/insecticide**, not a therapeutic drug used in clinical practice. In many standard pharmacological classifications (like Goodman & Gilman), carbamate insecticides are grouped separately from reversible clinical agents due to their high toxicity and prolonged binding. **Analysis of Incorrect Options:** * **A. Edrophonium:** A very short-acting reversible alcohol (quaternary ammonium). It binds only to the anionic site of AChE. It is classically used in the **Tensilon test** for Myasthenia Gravis. * **B. Demecarium:** A reversible carbamate derivative (essentially two neostigmine molecules linked). It is used topically in the management of glaucoma. * **D. Physostigmine (likely intended by 'Twine'):** Assuming the option refers to a clinical reversible carbamate like Physostigmine or Neostigmine, these are standard reversible inhibitors that form a carbamylated enzyme complex which dissociates over minutes to hours. **NEET-PG High-Yield Pearls:** 1. **Edrophonium:** Shortest acting (5-15 mins); used to differentiate Myasthenic crisis from Cholinergic crisis. 2. **Organophosphates:** Truly irreversible inhibitors (e.g., Malathion, Parathion, Nerve gases) that lead to "aging" of the enzyme. 3. **Pralidoxime (2-PAM):** The enzyme reactivator used in organophosphate poisoning, but it is ineffective against carbamate (like Carbaryl) poisoning. 4. **Donepezil/Rivastigmine:** Centrally acting reversible anticholinesterases used in Alzheimer’s disease.

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free